TP53 and breast carcinoma: After immunohistochemical evaluation of p53 expression in primary breast cancer specimens, it was assessed that p53 overexpression was associated with an advanced-stage tumor, metastatic spread, and lower concentrations of progesterone receptors (Table 1) [89].